A cost-effectiveness analysis of three antimalarial treatments for acute, uncomplicated Plasmodium falciparum malaria in Mumbai, India.

Gogtay, N J; Kadam, V S; Desai, S; Kamtekar, K D; Dalvi, S S; Kshirsagar, N A

Gogtay, N J; Kadam, V S; Desai, S; Kamtekar, K D; Dalvi, S S; Kshirsagar, N A.

Article in En | IMSEAR | ID: sea-95564

Subject(s)

Antimalarials/economics; Artemisinins/economics; Chloroquine/economics; Clinical Trials as Topic/economics; Cost-Benefit Analysis; Drug Combinations; Economics, Pharmaceutical; Female; Fluorenes/economics; Hospitalization/economics; Humans; India; Malaria, Falciparum/drug therapy; Male; Mefloquine/economics; Sesquiterpenes/economics

Fulltext

Add to My VHL

XML

Search on Google

Full text: 1 Index: IMSEAR Main subject: Sesquiterpenes / Female / Humans / Male / Mefloquine / Chloroquine / Clinical Trials as Topic / Malaria, Falciparum / Cost-Benefit Analysis / Economics, Pharmaceutical Type of study: Health_economic_evaluation Country/Region as subject: Asia Language: En Year: 2003 Type: Article

Fulltext

Add to My VHL

XML

Search on Google